Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes
Status:
Unknown status
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
Aim Evidence of a possible connection between gut microbiota and several physiological
processes linked to type 1 diabetes is increasing. However, the effect of multistrain
probiotics in people with type 1 diabetes remains unclear. This study investigated the effect
of metformin as add-on therapy on glycemic control and other diabetes-related outcomes in
people with type 1 diabetes.